Upload
zona
View
36
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Toll-like Receptor (TLR) 9 variant is associated with mother-to-child transmission (MTCT) of HIV-1 and TLR9 and TLR8 variants are associated with peak viral load in HIV-1 infected infants. Kristin Beima-Sofie , MPH, PhDc AIDS 2012 Abstract # MOPDA0101 Monday July 23, 2012. - PowerPoint PPT Presentation
Citation preview
Toll-like Receptor (TLR) 9 variant is associated with mother-to-child
transmission (MTCT) of HIV-1 and TLR9 and TLR8 variants are associated with
peak viral load in HIV-1 infected infants
Kristin Beima-Sofie, MPH, PhDcAIDS 2012 Abstract #MOPDA0101
Monday July 23, 2012
Washington D.C., USA, 22-27 July 2012www.aids2012.org
Toll-like Receptor (TLR) Polymorphisms and Infant HIV Acquisition and Disease
Progression
TLRs Critical proteins of the innate
immune system involved in pathogen recognition
Study Population Historical MTCT cohort from
Nairobi Kenya
Genotyping 6 candidate SNPs and 118 haplotype-tagging SNPs
396 infants
317 HIV uninfecte
d
Lower peak VLDecreased mortality
Higher peak VLIncreased mortality
79 HIV infected
Washington D.C., USA, 22-27 July 2012www.aids2012.org
TLR9 Variant is Associated with HIV AcquisitionAcquisition
15% of infants HIV positive by month 1 4.8% acquired HIV between month 1 and months 12
One or more copies of TLR9 1635A variant is significantly associated with acquisition by month 1 and month 12
First study to identify a variant in TLR9 that is associated with HIV acquisition in an African MTCT cohort
Washington D.C., USA, 22-27 July 2012www.aids2012.org
TLR7, TLR8 and TLR9 variants are associated with Peak Viral Load
Peak Viral Load Mean peak viral load in HIV infected infants: 6.8 log10 c/ml Novel TLR7 and candidateTLR8 and TLR9 variants are associated with peak
VL
*First study to identify variations in TLR7 and TLR8 that are associated with peak VL in HIV-infected infants
Mortality No SNPs were significantly associated with mortality
p=0.0009p=0.0021 p=0.0003
Washington D.C., USA, 22-27 July 2012www.aids2012.org
Acknowledgements
We gratefully acknowledge and appreciate the participation of study participants and study
staff from Nairobi, Kenya
NIH Funding Sources R21 AI073115 TL1 TR000422 R01 HD3412 R24 TW007988